Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
R. A. Lobo, A. M. Kaunitz, N. Santoro, B. Bernick, S. Graham & S. Mirkin. (2019) Metabolic and cardiovascular effects of TX-001HR in menopausal women with vasomotor symptoms. Climacteric 22:6, pages 610-616.
Read now
Read now
David F. Archer, Brian A. Bernick & Sebastian Mirkin. (2019) A combined, bioidentical, oral, 17β-estradiol and progesterone capsule for the treatment of moderate to severe vasomotor symptoms due to menopause. Expert Review of Clinical Pharmacology 12:8, pages 729-739.
Read now
Read now
Articles from other publishers (13)
Sophie Behrman & Clair Crockett. (2023) Severe mental illness and the perimenopause. BJPsych Bulletin, pages 1-7.
Crossref
Crossref
Nick Panay, Rossella E. Nappi, Petra Stute, Santiago Palacios, Tomasz Paszkowski, Risa Kagan, David F. Archer, Julie Héroux & Mitra Boolell. (2023) Oral estradiol/micronized progesterone may be associated with lower risk of venous thromboembolism compared with conjugated equine estrogens/medroxyprogesterone acetate in real-world practice. Maturitas 172, pages 23-31.
Crossref
Crossref
Ana C. Valencia‐Olvera, Juan Maldonado Weng, Amy Christensen, Mary Jo LaDu & Christian J. Pike. (2022)
Role of estrogen in women's Alzheimer's disease risk as modified by
APOE
. Journal of Neuroendocrinology 35:2.
Crossref
Crossref
Hilde LöfqvistHilde Löfqvist. 2022. Modern Menopausal Hormone Treatment. Modern Menopausal Hormone Treatment
47
53
.
Hilde LöfqvistHilde Löfqvist. 2022. Modern Menopausal Hormone Treatment. Modern Menopausal Hormone Treatment
27
45
.
Hilde LöfqvistHilde Löfqvist. 2021. Hormontherapie in den Wechseljahren. Hormontherapie in den Wechseljahren
47
57
.
Hilde LöfqvistHilde Löfqvist. 2021. Hormontherapie in den Wechseljahren. Hormontherapie in den Wechseljahren
27
45
.
Eitan Pe’er. 2021. Progestogens in Obstetrics and Gynecology. Progestogens in Obstetrics and Gynecology
193
202
.
James H. Liu, Denise R. Black, Lisa Larkin, Shelli GrahamBrian BernickSebastian Mirkin. (2020) Breast effects of oral, combined 17β-estradiol, and progesterone capsules in menopausal women: a randomized controlled trial. Menopause 27:12, pages 1388-1395.
Crossref
Crossref
Adriene M. Beltz & Jason S. Moser. (2020) Ovarian hormones: a long overlooked but critical contributor to cognitive brain structures and function. Annals of the New York Academy of Sciences 1464:1, pages 156-180.
Crossref
Crossref
Jan J. Stepan, Hana Hruskova & Miloslav Kverka. (2019) Update on Menopausal Hormone Therapy for Fracture Prevention. Current Osteoporosis Reports 17:6, pages 465-473.
Crossref
Crossref
Rogerio A. Lobo, James Liu, Frank Z. Stanczyk, Ginger D. Constantine, James H. Pickar, Annette M. ShadiackBrian BernickSebastian Mirkin. (2019) Estradiol and progesterone bioavailability for moderate to severe vasomotor symptom treatment and endometrial protection with the continuous-combined regimen of TX-001HR (oral estradiol and progesterone capsules). Menopause 26:7, pages 720-727.
Crossref
Crossref
Rafael Sánchez-Borrego. 2019. Postmenopausal Diseases and Disorders. Postmenopausal Diseases and Disorders
327
348
.